Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Jennell White, PhD
Researcher Assistant Professor
Wayne State University
School of Medicine
540 E. Canfield Ave.
Detroit, Michigan, United States
Dr. Jennell White is an Assistant Professor at the Wayne State University School of Medicine (WSU-SOM) in the Department of Pharmacology. Dr. White’s research focuses on mechanisms regulating sickle erythrocyte adhesive interactions during physiologic flow conditions.
Dr. White co-developed a process to utilize microliter whole blood volumes to establish normal ranges of adhesion indices in patients with SCD, to establish the relationship of standardized adhesion indices to vaso-occlusive pathology, and to assess the effect of disease modifying therapies. This process has been utilized by numerous pharmaceutical companies and research scientists to objectively assess the effect of a wide range of therapies using adhesion as a biomarker.
The emergences of novel, anti-adhesive therapies for sickle cell disease necessitate the adoption of standardized erythrocyte adhesion bioassays to define the relationship of adhesion to vaso-occlusive pathology and assess the effect of anti-adhesive drug therapy. Dr. White is optimistic that her research will help to address this unmet need.
Related Content
-
Barbara Speller Brown, DNP, MSNBarbara Speller-Brown, DNP, MSN, PNP-BC,...
-
CMO Speaks: Making ED Care Better for SCD – Progress in 2023Welcome to CMO Speaks, a blog featuring ...
-
Patricia Kavanagh, MDPatricia Kavanagh, MD, is an Assistant P...
-
Acute Care Utilization in Pediatric Sickle Cell Disease and Sickle Cell Trait in the USA: Prevalence, Temporal Trend...The objective of this study was to analy...
-
University of Pittsburgh School of MedicineThe University of Pittsburgh School of M...
-
Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)GBT440 is First Potential Treatment for ...
-
Opioid management strategy decreases admissions in high-utilizing adults with sickle cell diseaseBackground: A subset of adults with sic...